Shares of Moderna were surging in Monday’s trading session after the company revealed positive data on its early stage coronavirus vaccine trial. The early stage human trial for a coronavirus vaccine had produced antibodies in all of its 45 participants. At day 43, or two weeks after the second dose, levels of binding antibodies in … Continue reading “Moderna Shares Soar on Positive Results on Early Stage Coronavirus Vaccine Trial”
